Novartis Investigative Site

Cartegena, Colombia

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerosis, Cardiovascular Events, Heart Failure With Reduced Ejection Fraction

Studies at this site

• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early
• A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People — Stopped early